...
首页> 外文期刊>BMJ: British medical journal >Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
【24h】

Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

机译:β受体阻滞剂治疗慢性的影响阻塞性肺疾病:一个回顾队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY QUESTION Do beta blockers reduce mortality and exacerbations when added to established pharmacological management for chronic obstructive pulmonary disease (COPD)? SUMMARY ANSWER Yes, p blockers reduced all cause mortality, emergency oral corticosteroid use, and hospital admissions for respiratory disease when added to established inhaled stepwise therapy for COPD (including long acting beta agonists and antimuscarinics). WHAT IS KNOWN AND WHATTHIS PAPER ADDS beta blockers are avoided in patients with COPD because of concerns of bronchospasm and blocking the effects of beta agonists. Studies have suggested that p blockers may be beneficial in COPD patients but did not assess these benefits when stratified by concurrent drug treatments. This study assessed the interrelationship of beta blockers with beta agonists and other concurrent inhaler therapy, and showed that they reduced mortality and exacerbations in COPD patients when added to established inhaled stepwise therapy.
机译:研究的问题做了β受体阻滞剂减少死亡率并添加到建立时加重慢性药物管理阻塞性肺疾病(COPD) ?回答是的,p阻滞剂减少所有的原因死亡率、紧急口服皮质类固醇的使用,和入院时呼吸道疾病添加到吸入逐步建立治疗慢性阻塞性肺病(包括长β受体激动剂antimuscarinics)。纸避免添加β-受体阻滞药的病人慢性阻塞性肺病由于支气管痉挛和担忧阻断β受体激动剂的影响。表明,p阻滞剂可能是有益的在慢性阻塞性肺病患者但没有评估这些利益分层时并发的药物治疗方法。相互关系与ββ受体阻滞剂受体激动剂和其他并发吸入剂治疗,和显示,他们降低了死亡率和在慢性阻塞性肺病加重病人在添加的时候出现吸入逐步建立治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号